HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 92/1/221    most recent 00076.2004v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (11) Citing Articles via Google Scholar Google Scholar Articles by Kohlmeier, K. A. Articles by Leonard, C. S. Search for Related Content PubMed PubMed Citation Articles by Kohlmeier, K. A. Articles by Leonard, C. S.

Hypocretin/Orexin Peptide Signaling in the Ascending Arousal System: Elevation of Intracellular Calcium in the Mouse Dorsal Raphe and Laterodorsal Tegmentum

¹Department of Physiology, New York Medical College, Valhalla, New York 10595; and ²Division of Molecular Neurobiology, The Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan

Submitted 23 January 2004; accepted in final form 27 February 2004

Dysfunction of the hypocretin/orexin (Hcrt/Orx) peptide system is closely linked to the sleep disorder narcolepsy, suggesting that it is also central to the normal regulation of sleep and wakefulness. Indeed, Hcrt/Orx peptides produce long-lasting excitation of arousal-related neurons, including those in the laterodorsal tegmentum (LDT) and the dorsal raphe (DR), although the mechanisms underlying these actions are not understood. Since Hcrt/Orx mobilizes intracellular calcium ([Ca²⁺]_i) in cells transfected with orexin receptors and since receptor-mediated Ca²⁺ transients are ubiquitous signaling mechanisms, we investigated whether Hcrt/Orx regulates [Ca²⁺]_i in the LDT and DR. Changes in [Ca²⁺]_i were monitored by fluorescence changes of fura-2 AM loaded cells in young mouse brain slices. We found Hcrt/Orx (Orexin-A, 30-1,000 nM) evoked long-lasting increases in [Ca²⁺]_i with differing temporal profiles ranging from spiking to smooth plateaus. A fragment of Hcrt/Orx (16-33) failed to evoke changes in [Ca²⁺]_i and changes were not blocked by TTX or ionotropic glutamate receptor antagonists, suggesting they resulted from specific activation of postsynaptic orexin receptors. Unlike orexin receptor–transfected cells, Hcrt/Orx-responses were not attenuated by depletion of Ca²⁺ stores with cyclopiazonic acid (CPA; 3-30 µM), thapsigargin (3 µM), or ryanodine (20 µM), although store-depletion by either CPA or ryanodine blocked Ca²⁺ mobilization by the metabotropic glutamate receptor agonist (±)-1-aminocyclopentane-trans-1,3-dicarboxylic acid (trans-ACPD; 30 µM). In contrast, Hcrt/Orx responses were strongly attenuated by lowering extracellular Ca²⁺ (20 µM) but were not inhibited by concentrations of KB-R7943 (10 µM) selective for blockade of sodium/calcium exchange. Nifedipine (10 µM), inhibited Hcrt/Orx responses but was more effective at abolishing spiking than plateau responses. Bay K 8644 (5-10 µM), an L-type calcium channel agonist, potentiated responses. Finally, responses were attenuated by inhibitors of protein kinase C (PKC) but not by inhibitors of adenylyl cyclase. Collectively, our findings indicate that Hcrt/Orx signaling in the reticular activating system involves elevation of [Ca²⁺]_i by a PKC-involved influx of Ca²⁺ across the plasma membrane, in part, via L-type calcium channels. Thus the physiological release of Hcrt/Orx may help regulate Ca²⁺-dependent processes such as gene expression and NO production in the LDT and DR in relation with behavioral state. Accordingly, the loss of Hcrt/Orx signaling in narcolepsy would be expected to disrupt calcium-dependent processes in these and other target structures.

This article has been cited by other articles:

				R. SZYMUSIAK and D. MCGINTY Hypothalamic Regulation of Sleep and Arousal Ann. N.Y. Acad. Sci., May 1, 2008; 1129(1): 275 - 286. [Abstract] [Full Text] [PDF]

				X.-W. Chen, Y. Mu, H.-P. Huang, N. Guo, B. Zhang, S.-Y. Fan, J.-X. Xiong, S.-R. Wang, W. Xiong, W. Huang, et al. Hypocretin-1 Potentiates NMDA Receptor-Mediated Somatodendritic Secretion from Locus Ceruleus Neurons J. Neurosci., March 19, 2008; 28(12): 3202 - 3208. [Abstract] [Full Text] [PDF]

				J. Nasman, G. Bart, K. Larsson, L. Louhivuori, H. Peltonen, and K. E. O. Akerman The Orexin OX1 Receptor Regulates Ca2+ Entry via Diacylglycerol-Activated Channels in Differentiated Neuroblastoma Cells. J. Neurosci., October 18, 2006; 26(42): 10658 - 10666. [Abstract] [Full Text] [PDF]

				T. Holmqvist, L. Johansson, M. Ostman, S. Ammoun, K. E. O. Akerman, and J. P. Kukkonen OX1 Orexin Receptors Couple to Adenylyl Cyclase Regulation via Multiple Mechanisms J. Biol. Chem., February 25, 2005; 280(8): 6570 - 6579. [Abstract] [Full Text] [PDF]

				S. Haj-Dahmane and R.-Y. Shen The Wake-Promoting Peptide Orexin-B Inhibits Glutamatergic Transmission to Dorsal Raphe Nucleus Serotonin Neurons through Retrograde Endocannabinoid Signaling J. Neurosci., January 26, 2005; 25(4): 896 - 905. [Abstract] [Full Text] [PDF]

				K. P. Larsson, H. M. Peltonen, G. Bart, L. M. Louhivuori, A. Penttonen, M. Antikainen, J. P. Kukkonen, and K. E. O. Akerman Orexin-A-induced Ca2+ Entry: EVIDENCE FOR INVOLVEMENT OF TRPC CHANNELS AND PROTEIN KINASE C REGULATION J. Biol. Chem., January 21, 2005; 280(3): 1771 - 1781. [Abstract] [Full Text] [PDF]